
Global Gene Synthesis Market by Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), by Service Type (Antibody DNA Synthesis, Viral DNA Synthesis, Other Service Types), by Application (Gene & Cell Therapy Development, Vaccine
Description
Global Gene Synthesis Market by Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), by Service Type (Antibody DNA Synthesis, Viral DNA Synthesis, Other Service Types), by Application (Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis, Others), by End-User (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations), and by Region - 2023 to 2033
Gene Synthesis Market – Scope of Report
TMR’s report on the global gene synthesis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global gene synthesis market for the period 2017–2031, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global gene synthesis market from 2023 to 2033.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the gene synthesis market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global gene synthesis market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global gene synthesis market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global gene synthesis market.
The report delves into the competitive landscape of the global gene synthesis market. Key players operating in the global gene synthesis market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global gene synthesis market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market gene synthesis.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
Gene Synthesis Market – Scope of Report
TMR’s report on the global gene synthesis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global gene synthesis market for the period 2017–2031, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global gene synthesis market from 2023 to 2033.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the gene synthesis market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global gene synthesis market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global gene synthesis market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global gene synthesis market.
The report delves into the competitive landscape of the global gene synthesis market. Key players operating in the global gene synthesis market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global gene synthesis market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market gene synthesis.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
- Industry Sources:
- WorldWideScience.org
- Elsevier, Inc.
- National Institutes of Health (NIH)
- PubMed
- NCBI
- Department of Health Care Service
- Trade Data Sources
- Trade Map
- UN Comtrade
- Trade Atlas
- Company Information
- OneSource Business Browser
- Hoover’s
- Factiva
- Bloomberg
- Mergers & Acquisitions
- Thomson Mergers & Acquisitions
- MergerStat
- Profound
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
Table of Contents
250 Pages
- 1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Summary of Statistics
- 1.3. Key Market Characteristics & Attributes
- 1.4. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage
- 2.2. Market Definition
- 3. Market Risks and Trends Assessment
- 3.1. Risk Assessment
- 3.1.1. COVID-19 Crisis and Impact on Gene Synthesis
- 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
- 3.1.3. Impact on Market Value (US$ Mn)
- 3.1.4. Assessment by Key Countries
- 3.1.5. Assessment by Key Market Segments
- 3.1.6. Action Points and Recommendation for Suppliers
- 3.2. Key Trends Impacting the Market
- 3.3. Formulation and Product Development Trends
- 4. Market Background
- 4.1. Gene Synthesis Market, by Key Countries
- 4.2. Gene Synthesis Market Opportunity Assessment (US$ Mn)
- 4.2.1. Total Available Market
- 4.2.2. Serviceable Addressable Market
- 4.2.3. Serviceable Obtainable Market
- 4.3. Market Scenario Forecast
- 4.3.1. Demand in optimistic Scenario
- 4.3.2. Demand in Likely Scenario
- 4.3.3. Demand in Conservative Scenario
- 4.4. Investment Feasibility Analysis
- 4.4.1. Investment in Established Markets
- 4.4.1.1. In Short Term
- 4.4.1.2. In Long Term
- 4.4.2. Investment in Emerging Markets
- 4.4.2.1. In Short Term
- 4.4.2.2. In Long Term
- 4.5. Forecast Factors - Relevance & Impact
- 4.5.1. Top Companies Historical Growth
- 4.5.2. Growth in Automation, By Country
- 4.5.3. Gene Synthesis Adoption Rate, By Country
- 4.6. Market Dynamics
- 4.6.1. Market Driving Factors and Impact Assessment
- 4.6.2. Prominent Market Challenges and Impact Assessment
- 4.6.3. Gene Synthesis Market Opportunities
- 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
- 5. Key Success Factors
- 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
- 5.2. Banking on with Segments High Incremental Opportunity
- 5.3. Peer Benchmarking
- 6. Global Gene Synthesis Market Demand Analysis 2018-2022 and Forecast, 2023-2033
- 6.1. Historical Market Analysis, 2018-2022
- 6.2. Current and Future Market Projections, 2023-2033
- 6.3. Y-o-Y Growth Trend Analysis
- 7. Global Gene Synthesis Market Value Analysis 2018-2022 and Forecast, 2023-2033
- 7.1. Historical Market Value (US$ Mn) Analysis, 2018-2022
- 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
- 8. Global Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033, By Method
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Mn) Analysis By Method, 2018-2022
- 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Method, 2023-2033
- 8.3.1. Solid-phase Synthesis
- 8.3.2. Chip-based Synsthesis
- 8.3.3. PCR-based Enzyme Synthesis
- 8.4. Market Attractiveness Analysis By Method
- 9. Global Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033, By Service Type
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Mn) Analysis By Service Type, 2018-2022
- 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Service Type, 2023-2033
- 9.3.1. Antibody DNA Synthesis
- 9.3.2. Viral DNA Synthesis
- 9.3.3. Other Service Types
- 9.4. Market Attractiveness Analysis By Service Type
- 10. Global Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033, By Application
- 10.1. Introduction / Key Findings
- 10.2. Historical Market Size (US$ Mn) Analysis By Application, 2018-2022
- 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2023-2033
- 10.3.1. Gene & Cell Therapy Development
- 10.3.2. Vaccine Development
- 10.3.3. Disease Diagnosis
- 10.3.4. Others
- 10.4. Market Attractiveness Analysis By Application
- 11. Global Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033, By End-User
- 11.1. Introduction/Key Findings
- 11.2. Historical Market Size (US$ Mn) Analysis By End-User, 2018-2022
- 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-User, 2023-2033
- 11.3.1. Biotechnology & Pharmaceutical Companies
- 11.3.2. Academic & Government Research Institutes
- 11.3.3. Contract Research Organization
- 11.4. Market Attractiveness Analysis By End-User
- 12. Global Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033, By Region
- 12.1. Introduction
- 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2018-2022
- 12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2023-2033
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. Asia Pacific
- 12.3.5. Middle East and Africa (MEA)
- 12.4. Market Attractiveness Analysis By Region
- 13. North America Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033
- 13.1. Introduction
- 13.2. Pricing Analysis
- 13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
- 13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
- 13.4.1. By Country
- 13.4.1.1. U.S.
- 13.4.1.2. Canada
- 13.4.1.3. Rest of North America
- 13.4.2. By Method
- 13.4.3. By Service Type
- 13.4.4. By End-User
- 13.4.5. By Application
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Country
- 13.5.2. By Method
- 13.5.3. By Service Type
- 13.5.4. By End-User
- 13.5.5. By Application
- 14. Latin America Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033
- 14.1. Introduction
- 14.2. Pricing Analysis
- 14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
- 14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
- 14.4.1. By Country
- 14.4.1.1. Brazil
- 14.4.1.2. Mexico
- 14.4.1.3. Rest of Latin America
- 14.4.2. By Method
- 14.4.3. By Service Type
- 14.4.4. By End-User
- 14.4.5. By Application
- 14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Method
- 14.5.3. By Service Type
- 14.5.4. By End-User
- 14.5.5. By Application
- 15. Europe Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033
- 15.1. Introduction
- 15.2. Pricing Analysis
- 15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
- 15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
- 15.4.1. By Country
- 15.4.1.1. Germany
- 15.4.1.2. France
- 15.4.1.3. U.K.
- 15.4.1.4. Italy
- 15.4.1.5. Benelux
- 15.4.1.6. Nordic Countries
- 15.4.1.7. Rest of Europe
- 15.4.2. By Method
- 15.4.3. By Service Type
- 15.4.4. By End-User
- 15.4.5. By Application
- 15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Method
- 15.5.3. By Service Type
- 15.5.4. By End-User
- 15.5.5. By Application
- 16. Asia Pacific Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033
- 16.1. Introduction
- 16.2. Pricing Analysis
- 16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
- 16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
- 16.4.1. By Country
- 16.4.1.1. China
- 16.4.1.2. Japan
- 16.4.1.3. South Korea
- 16.4.1.4. Rest of Asia Pacific
- 16.4.2. By Method
- 16.4.3. By Service Type
- 16.4.4. By End-User
- 16.4.5. By Application
- 16.5. Market Attractiveness Analysis
- 16.5.1. By Country
- 16.5.2. By Method
- 16.5.3. By Service Type
- 16.5.4. By End-User
- 16.5.5. By Application
- 17. Middle East and Africa Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033
- 17.1. Introduction
- 17.2. Pricing Analysis
- 17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
- 17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
- 17.4.1. By Country
- 17.4.1.1. GCC Countries
- 17.4.1.2. South Africa
- 17.4.1.3. Turkey
- 17.4.1.4. Rest of Middle East and Africa
- 17.4.2. By Method
- 17.4.3. By Service Type
- 17.4.4. By End-User
- 17.4.5. By Application
- 17.5. Market Attractiveness Analysis
- 17.5.1. By Country
- 17.5.2. By Method
- 17.5.3. By Service Type
- 17.5.4. By End-User
- 17.5.5. By Application
- 18. Key Countries Gene Synthesis Market Analysis 2018-2022 and Forecast 2023-2033
- 18.1. Introduction
- 18.1.1. Market Value Proportion Analysis, By Key Countries
- 18.1.2. Global Vs. Country Growth Comparison
- 18.2. US Gene Synthesis Market Analysis
- 18.2.1. Value Proportion Analysis by Market Taxonomy
- 18.2.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.2.2.1. By Method
- 18.2.2.2. By Service Type
- 18.2.2.3. By End-User
- 18.2.2.4. By Application
- 18.3. Canada Gene Synthesis Market Analysis
- 18.3.1. Value Proportion Analysis by Market Taxonomy
- 18.3.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.3.2.1. By Method
- 18.3.2.2. By Service Type
- 18.3.2.3. By End-User
- 18.3.2.4. By Application
- 18.4. Mexico Gene Synthesis Market Analysis
- 18.4.1. Value Proportion Analysis by Market Taxonomy
- 18.4.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.4.2.1. By Method
- 18.4.2.2. By Service Type
- 18.4.2.3. By End-User
- 18.4.2.4. By Application
- 18.5. Brazil Gene Synthesis Market Analysis
- 18.5.1. Value Proportion Analysis by Market Taxonomy
- 18.5.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.5.2.1. By Method
- 18.5.2.2. By Service Type
- 18.5.2.3. By End-User
- 18.5.2.4. By Application
- 18.6. Germany Gene Synthesis Market Analysis
- 18.6.1. Value Proportion Analysis by Market Taxonomy
- 18.6.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.6.2.1. By Method
- 18.6.2.2. By Service Type
- 18.6.2.3. By End-User
- 18.6.2.4. By Application
- 18.7. France Gene Synthesis Market Analysis
- 18.7.1. Value Proportion Analysis by Market Taxonomy
- 18.7.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.7.2.1. By Method
- 18.7.2.2. By Service Type
- 18.7.2.3. By End-User
- 18.7.2.4. By Application
- 18.8. Italy Gene Synthesis Market Analysis
- 18.8.1. Value Proportion Analysis by Market Taxonomy
- 18.8.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.8.2.1. By Method
- 18.8.2.2. By Service Type
- 18.8.2.3. By End-User
- 18.8.2.4. By Application
- 18.9. BENELUX Gene Synthesis Market Analysis
- 18.9.1. Value Proportion Analysis by Market Taxonomy
- 18.9.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.9.2.1. By Method
- 18.9.2.2. By Service Type
- 18.9.2.3. By End-User
- 18.9.2.4. By Application
- 18.10. UK Gene Synthesis Market Analysis
- 18.10.1. Value Proportion Analysis by Market Taxonomy
- 18.10.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.10.2.1. By Method
- 18.10.2.2. By Service Type
- 18.10.2.3. By End-User
- 18.10.2.4. By Application
- 18.11. Nordic Countries Gene Synthesis Market Analysis
- 18.11.1. Value Proportion Analysis by Market Taxonomy
- 18.11.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.11.2.1. By Method
- 18.11.2.2. By Service Type
- 18.11.2.3. By End-User
- 18.11.2.4. By Application
- 18.12. China Gene Synthesis Market Analysis
- 18.12.1. Value Proportion Analysis by Market Taxonomy
- 18.12.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.12.2.1. By Method
- 18.12.2.2. By Service Type
- 18.12.2.3. By End-User
- 18.12.2.4. By Application
- 18.13. Japan Gene Synthesis Market Analysis
- 18.13.1. Value Proportion Analysis by Market Taxonomy
- 18.13.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.13.2.1. By Method
- 18.13.2.2. By Service Type
- 18.13.2.3. By End-User
- 18.13.2.4. By Application
- 18.14. South Korea Gene Synthesis Market Analysis
- 18.14.1. Value Proportion Analysis by Market Taxonomy
- 18.14.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.14.2.1. By Method
- 18.14.2.2. By Service Type
- 18.14.2.3. By End-User
- 18.14.2.4. By Application
- 18.15. GCC Countries Gene Synthesis Market Analysis
- 18.15.1. Value Proportion Analysis by Market Taxonomy
- 18.15.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.15.2.1. By Method
- 18.15.2.2. By Service Type
- 18.15.2.3. By End-User
- 18.15.2.4. By Application
- 18.16. South Africa Gene Synthesis Market Analysis
- 18.16.1. Value Proportion Analysis by Market Taxonomy
- 18.16.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.16.2.1. By Method
- 18.16.2.2. By Service Type
- 18.16.2.3. By End-User
- 18.16.2.4. By Application
- 18.17. Turkey Gene Synthesis Market Analysis
- 18.17.1. Value Proportion Analysis by Market Taxonomy
- 18.17.2. Value Analysis and Forecast by Market Taxonomy, 2018-2033
- 18.17.2.1. By Method
- 18.17.2.2. By Service Type
- 18.17.2.3. By End-User
- 18.17.2.4. By Application
- 18.17.3. Competition Landscape and Player Concentration in the Country
- 19. Market Structure Analysis
- 19.1. Market Analysis by Tier of Companies
- 19.2. Market Concentration
- 19.3. Market Share Analysis of Top Players
- 19.4. Market Presence Analysis
- 19.4.1. By Regional footprint of Players
- 19.4.2. Product footprint by Players
- 20. Competition Analysis
- 20.1. Competition Dashboard
- 20.2. Competition Benchmarking
- 20.3. Competition Deep Dive
- 20.3.1. GenScript
- 20.3.1.1. Overview
- 20.3.1.2. Product Portfolio
- 20.3.1.3. Sales Footprint
- 20.3.1.4. Strategy Overview
- 20.3.2. Brooks Automation, Inc. (GENEWIZ)
- 20.3.2.1. Overview
- 20.3.2.2. Product Portfolio
- 20.3.2.3. Sales Footprint
- 20.3.2.4. Strategy Overview
- 20.3.3. Boster Biological Technology
- 20.3.3.1. Overview
- 20.3.3.2. Product Portfolio
- 20.3.3.3. Sales Footprint
- 20.3.3.4. Strategy Overview
- 20.3.4. Twist Bioscience
- 20.3.4.1. Overview
- 20.3.4.2. Product Portfolio
- 20.3.4.3. Sales Footprint
- 20.3.4.4. Strategy Overview
- 20.3.5. ProteoGenix
- 20.3.5.1. Overview
- 20.3.5.2. Product Portfolio
- 20.3.5.3. Sales Footprint
- 20.3.5.4. Strategy Overview
- 20.3.6. Biomatik
- 20.3.6.1. Overview
- 20.3.6.2. Product Portfolio
- 20.3.6.3. Sales Footprint
- 20.3.6.4. Strategy Overview
- 20.3.7. ProMab Biotechnologies, Inc.
- 20.3.7.1. Overview
- 20.3.7.2. Product Portfolio
- 20.3.7.3. Sales Footprint
- 20.3.7.4. Strategy Overview
- 20.3.8. Thermo Fisher Scientific, Inc.
- 20.3.8.1. Overview
- 20.3.8.2. Product Portfolio
- 20.3.8.3. Sales Footprint
- 20.3.8.4. Strategy Overview
- 20.3.9. Integrated DNA Technologies, Inc.
- 20.3.9.1. Overview
- 20.3.9.2. Product Portfolio
- 20.3.9.3. Sales Footprint
- 20.3.9.4. Strategy Overview
- 20.3.10. OriGene Technologies, Inc.
- 20.3.10.1. Overview
- 20.3.10.2. Product Portfolio
- 20.3.10.3. Sales Footprint
- 20.3.10.4. Strategy Overview
- 21. Assumptions and Acronyms Used
- 22. Research Methodology
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.